PRECIS-2 - Details

Chaiqin Chengqi Decoction for Acute Pancreatitis (CQCQDAP trial): study protocol of a randomized, double-blind, placebo-controlled, parallel-group trial

Acute pancreatitis (AP) is the common digestive disease with a potentially high risk of mortality. Traditional Chinese medicinal fomula Chaiqin Chengqi Decoction (CQCQD) has been used for the management of AP in West China Hospital for decades. CQCQD for AP (CQCQDAP) trial tests whether the administration of CQCQD will improve the efficacy of the present comprehensive treatments for AP.

Trial

Journal Ref.	Unpublished
Intervention	Drug - Chaiqin Chengqi Decoction (CQCQD) and placebo CQCQD will be used for the treatment of acute pancreatitis.
Number of sites	1
Countries involved	China
Sample size	248
Type of statistical analyses
Risk of bias	Overall: Low Risk details Random sequence generation: Low Risk Allocation concealment: Low Risk Blinding of participants, personal and outcome assessors: Low Risk Incomplete outcome data: Low Risk Selective outcome reporting: Low Risk Other sources of bias: Low Risk
Duration of trial
Primary outcome	Duration of respiratory failure

Show Score Ranges

Scores:

(shows median if more than one score was entered)

Elig.	Recr.	Setting	Org. Int.	Flex. Del.	Flex. Adherence	Follow-Up	Prim. Out.	Prim. An.
4	5	3	5	5	4	4	5	3

View Scores Back to List